SCHEMBL29488479

SCHEMBL29488479

O=C(CCCC/C=C(\COc1cccc2ccccc12)C(=O)NC1CCN(C2CC2)CC1)NO

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX3 P56373 1/20 0.39
▸ PREP P48147 2/20 0.39
▸ HDAC1 Q13547 5/20 0.38
▸ HDAC6 Q9UBN7 5/20 0.38
▸ HDAC3 O15379 4/20 0.38
▸ HDAC2 Q92769 4/20 0.38
▸ HDAC4 P56524 3/20 0.38
▸ HDAC7 Q8WUI4 3/20 0.38
▸ HDAC10 Q969S8 3/20 0.38
▸ HDAC11 Q96DB2 3/20 0.38
▸ HDAC8 Q9BY41 3/20 0.38
▸ HDAC9 Q9UKV0 3/20 0.38
▸ HDAC5 Q9UQL6 3/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ OGG1 O15527 1/20 0.38
▸ MAPT P10636 2/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1306054 1.00 P2RX3 (0.39) P2RX3PREPHDAC1HDAC6HDAC3
SCHEMBL1306050 1.00 P2RX3 (0.39) P2RX3PREPHDAC1HDAC6HDAC3
SCHEMBL1306742 0.97 HDAC1 (0.41) P2RX3PREPHDAC1HDAC6HDAC3
SCHEMBL29488469 0.97 HDAC1 (0.41) P2RX3PREPHDAC1HDAC6HDAC3
SCHEMBL1306745 0.97 HDAC1 (0.41) P2RX3PREPHDAC1HDAC6HDAC3
SCHEMBL1306269 0.96 P2RX3 (0.40) P2RX3PREPHDAC1HDAC6HDAC3
SCHEMBL29488483 0.96 P2RX3 (0.40) P2RX3PREPHDAC1HDAC6HDAC3
SCHEMBL1306273 0.96 P2RX3 (0.40) P2RX3PREPHDAC1HDAC6HDAC3
SCHEMBL1306207 0.92 ALDH1A1 (0.44) P2RX3PREPALDH1A1KDM4EHPGD
SCHEMBL1306209 0.92 ALDH1A1 (0.44) P2RX3PREPALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114340672-A Pharmaceutical composition comprising an HDAC inhibitor and an anti-PD 1 antibody or an anti-PD-L1 antibody 晶体基因技术株式会社 2022-04-12 — — CN claimed
CN-114340672-A Pharmaceutical composition comprising an HDAC inhibitor and an anti-PD 1 antibody or an anti-PD-L1 antibody 晶体基因技术株式会社 2022-04-12 — — CN disclosed
CN-110740989-B Pharmaceutically acceptable salts of alkylcarbamoylnaphthoxyoctenoylhydroxyamides or derivatives thereof and process for preparing the same 晶体基因技术株式会社 2022-03-08 — — CN disclosed
Send feedback